Highlights –
- Samsung Biologics building new plant for future growth engines.
- The company will produce and manufacture biopharmaceutical products for major pharmaceutical firms.
- The new upcoming plant is said to be worth $1.4 billion.
- In 2020, the company recorded sales of around 1.16 trillion won for the first time.
South Korean pharmaceutical firm Sams....
Tags : SAMSUNG BIOLOGICS, BIOPHARMACEUTICAL PRODUCTS, CDMO BUSINESS, SAMSUNG BIOLOGICS CEO, JOHN RIM,
comments (0)